Compile Data Set for Download or QSAR
Found 61 Enz. Inhib. hit(s) with all data for entry = 50033933
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354066(CHEMBL1836324)copy SMILEScopy InChI
Affinity DataKi:  0.800nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354068(CHEMBL1836322)copy SMILEScopy InChI
Affinity DataKi:  0.900nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354077(CHEMBL1836331)copy SMILEScopy InChI
Affinity DataKi:  1.10nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354079(CHEMBL1836329)copy SMILEScopy InChI
Affinity DataKi:  1.10nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Rat 6B)
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354072(CHEMBL1836317)copy SMILEScopy InChI
Affinity DataKi:  1.40nMAssay Description:Antagonist activity at rat NPY5 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354070(CHEMBL1836319)copy SMILEScopy InChI
Affinity DataKi:  1.40nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354083(CHEMBL1836102 | N-{[(1r,4r)-4-{[(4-aminoquinazolin...)copy SMILEScopy InChI
Affinity DataKi:  1.40nMAssay Description:Binding affinity to NPY5 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354072(CHEMBL1836317)copy SMILEScopy InChI
Affinity DataKi:  1.5nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354078(CHEMBL1836330)copy SMILEScopy InChI
Affinity DataKi:  1.70nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354073(CHEMBL1836316)copy SMILEScopy InChI
Affinity DataKi:  1.90nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354081(CHEMBL1836327)copy SMILEScopy InChI
Affinity DataKi:  2.40nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354071(CHEMBL1836318)copy SMILEScopy InChI
Affinity DataKi:  2.80nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354064(CHEMBL1836326)copy SMILEScopy InChI
Affinity DataKi:  3.40nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354076(CHEMBL1836103)copy SMILEScopy InChI
Affinity DataKi:  4.90nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetSodium-dependent serotonin transporter(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354083(CHEMBL1836102 | N-{[(1r,4r)-4-{[(4-aminoquinazolin...)copy SMILEScopy InChI
Affinity DataKi:  6.20nMAssay Description:Inhibition of serotonin transporterMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354080(CHEMBL1836328)copy SMILEScopy InChI
Affinity DataKi:  6.70nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354082(CHEMBL1836321)copy SMILEScopy InChI
Affinity DataKi:  7.5nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354067(CHEMBL1836323)copy SMILEScopy InChI
Affinity DataKi:  8.80nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354075(CHEMBL1836314)copy SMILEScopy InChI
Affinity DataKi:  13.9nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354063(CHEMBL1836332)copy SMILEScopy InChI
Affinity DataKi:  16.1nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354074(CHEMBL1836315)copy SMILEScopy InChI
Affinity DataKi:  21.5nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354065(CHEMBL1836325)copy SMILEScopy InChI
Affinity DataKi:  27nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50089046(CHEMBL17022 | Naphthalene-2-sulfonic acid (4-{[(na...)copy SMILEScopy InChI
Affinity DataKi:  32nMAssay Description:Binding affinity to NPY5 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354069(CHEMBL1836320)copy SMILEScopy InChI
Affinity DataKi:  46nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
Target5-hydroxytryptamine receptor 2B(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354072(CHEMBL1836317)copy SMILEScopy InChI
Affinity DataKi:  245nMAssay Description:Binding affinity to human 5HT2B receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
Target5-hydroxytryptamine receptor 1A(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354072(CHEMBL1836317)copy SMILEScopy InChI
Affinity DataKi:  478nMAssay Description:Binding affinity to human 5HT1A receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 1(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50020168(1N-(2-methoxybenzyl)-6N-(2-{2-[6-(2-methoxybenzyla...)copy SMILEScopy InChI
Affinity DataKi:  1.80E+3nMAssay Description:Binding affinity to NPY1 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50020168(1N-(2-methoxybenzyl)-6N-(2-{2-[6-(2-methoxybenzyla...)copy SMILEScopy InChI
Affinity DataKi:  5.00E+3nMAssay Description:Binding affinity to NPY5 receptorMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354066(CHEMBL1836324)copy SMILEScopy InChI
Affinity DataIC50: 0.600nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354070(CHEMBL1836319)copy SMILEScopy InChI
Affinity DataIC50: 0.900nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354068(CHEMBL1836322)copy SMILEScopy InChI
Affinity DataIC50: 1.30nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354072(CHEMBL1836317)copy SMILEScopy InChI
Affinity DataIC50: 1.80nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354064(CHEMBL1836326)copy SMILEScopy InChI
Affinity DataIC50: 1.90nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354073(CHEMBL1836316)copy SMILEScopy InChI
Affinity DataIC50: 3.80nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354063(CHEMBL1836332)copy SMILEScopy InChI
Affinity DataIC50: 3.90nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354067(CHEMBL1836323)copy SMILEScopy InChI
Affinity DataIC50: 5nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354065(CHEMBL1836325)copy SMILEScopy InChI
Affinity DataIC50: 8.80nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354082(CHEMBL1836321)copy SMILEScopy InChI
Affinity DataIC50: 9.90nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354074(CHEMBL1836315)copy SMILEScopy InChI
Affinity DataIC50: 10.4nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354071(CHEMBL1836318)copy SMILEScopy InChI
Affinity DataIC50: 30.8nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354076(CHEMBL1836103)copy SMILEScopy InChI
Affinity DataIC50: 34.6nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354075(CHEMBL1836314)copy SMILEScopy InChI
Affinity DataIC50: 43.6nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 5(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354069(CHEMBL1836320)copy SMILEScopy InChI
Affinity DataIC50: 98.7nMAssay Description:Antagonist activity at human NPY5 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354073(CHEMBL1836316)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at human NPY2 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354072(CHEMBL1836317)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at human NPY2 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 2(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354071(CHEMBL1836318)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at human NPY2 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 4(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354076(CHEMBL1836103)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at human NPY4 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 4(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354073(CHEMBL1836316)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at human NPY4 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 4(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354072(CHEMBL1836317)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at human NPY4 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
TargetNeuropeptide Y receptor type 4(Homo sapiens (Human))
Lundbeck Research USA, Inc.

Curated by ChEMBL
LigandPNGBDBM50354071(CHEMBL1836318)copy SMILEScopy InChI
Affinity DataIC50: 1.00E+3nMAssay Description:Antagonist activity at human NPY4 receptor assessed as calcium mobilization by FLIPR assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2RN387KPubMed
Displayed 1 to 50 (of 61 total ) | Next | Last >>
Jump to: